loading page

Outcomes of Bovine versus Porcine Surgical Aortic Valve Replacement
  • +7
  • Sarah Yousef,
  • Yancheng Dai,
  • Edgar Aranda-Michel,
  • James Brown,
  • Derek Serna-Gallegos,
  • David Kaczorowski,
  • Johannes Bonatti,
  • Pyongsoo Yoon,
  • Danny Chu,
  • Ibrahim Sultan
Sarah Yousef
University of Pittsburgh Department of Cardiothoracic Surgery

Corresponding Author:[email protected]

Author Profile
Yancheng Dai
University of Pittsburgh School of Medicine
Author Profile
Edgar Aranda-Michel
University of Pittsburgh School of Medicine
Author Profile
James Brown
University of Pittsburgh Department of Cardiothoracic Surgery
Author Profile
Derek Serna-Gallegos
University of Pittsburgh Department of Cardiothoracic Surgery
Author Profile
David Kaczorowski
University of Pittsburgh Department of Cardiothoracic Surgery
Author Profile
Johannes Bonatti
University of Pittsburgh Department of Cardiothoracic Surgery
Author Profile
Pyongsoo Yoon
University of Pittsburgh Department of Cardiothoracic Surgery
Author Profile
Danny Chu
University of Pittsburgh Department of Cardiothoracic Surgery
Author Profile
Ibrahim Sultan
University of Pittsburgh Department of Cardiothoracic Surgery
Author Profile

Abstract

Introduction: There are no guidelines regarding the use of bovine pericardial or porcine valves for aortic valve replacement, and prior studies have yielded conflicting results. The current study sought to compare short- and long-term outcomes in propensity-matched cohorts of patients undergoing isolated AVR with bovine versus porcine valves. Methods: This was a retrospective study utilizing an institutional database of all isolated bioprosthetic surgical aortic valve replacements performed at our center from 2010 to 2020. Patients were stratified according to type of bioprosthetic valve (bovine pericardial or porcine), and 1:1 propensity-score matching was applied. Kaplan-Meier survival estimation and multivariable Cox regression for mortality were performed. Cumulative incidence functions were generated for all-cause readmissions and aortic valve reinterventions. Results: A total of 1,502 patients were identified, 1,090 (72.6%) of whom received a bovine prosthesis and 412 (27.4%) of whom received a porcine prosthesis. Propensity-score matching resulted in 412 risk-adjusted pairs. There were no significant differences in clinical or echocardiographic postoperative outcomes in the matched cohorts. Kaplan-Meier survival estimates were comparable, and, on multivariable Cox regression, valve type was not significantly associated with long-term mortality (HR 1.02, 95% CI: 0.74, 1.40, p=0.924). Additionally, there were no significant differences in competing-risk cumulative incidence estimates for all-cause readmissions (p=0.68) or aortic valve reinterventions (p=0.25) in the matched cohorts. Conclusion: The use of either bovine or porcine bioprosthetic aortic valves yields comparable postoperative outcomes, long-term survival, freedom from reintervention, and freedom from readmission.
29 Jul 2022Submitted to Journal of Cardiac Surgery
29 Jul 2022Submission Checks Completed
29 Jul 2022Assigned to Editor
01 Aug 2022Reviewer(s) Assigned
23 Aug 2022Review(s) Completed, Editorial Evaluation Pending
30 Aug 2022Editorial Decision: Revise Major
12 Sep 20221st Revision Received
12 Sep 2022Submission Checks Completed
12 Sep 2022Assigned to Editor
12 Sep 2022Reviewer(s) Assigned
23 Sep 2022Review(s) Completed, Editorial Evaluation Pending
23 Sep 2022Editorial Decision: Accept